Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)
Fanshawe TR. et al, (2024), Clinical Microbiology and Infection, 30, 380 - 386
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study
Nicholson BD. et al, (2023), The Lancet Oncology, 24, 733 - 743
Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation
Nicholson BD. et al, (2023), JOURNAL OF CLINICAL ONCOLOGY, 41
The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme)
Wang K. et al, (2023), Programme Grants for Applied Research, 11, vii - 57
Urine collection devices to reduce contamination in urine samples for diagnosis of uncomplicated UTI: A single-blind randomised controlled trial in primary care
Hayward G. et al, (2022), British Journal of General Practice, 72, 1 - 9
The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): A double-blind randomised placebo-controlled trial
Wang K. et al, (2021), European Respiratory Journal, 58
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Yu LM. et al, (2021), The Lancet, 398, 843 - 855
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Butler CC. et al, (2021), The Lancet Respiratory Medicine, 9, 1010 - 1020
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074
Association of frequent moisturizer use in early infancy with the development of food allergy.
Perkin MR. et al, (2021), J Allergy Clin Immunol, 147, 967 - 976.e1
Challenges experienced with early introduction and sustained consumption of allergenic foods in the Enquiring About Tolerance (EAT) study: A qualitative analysis.
Voorheis P. et al, (2019), J Allergy Clin Immunol, 144, 1615 - 1623
Efficacy of the Enquiring About Tolerance (EAT) study among infants at high risk of developing food allergy.
Perkin MR. et al, (2019), J Allergy Clin Immunol, 144, 1606 - 1614.e2
Factors influencing adherence in a trial of early introduction of allergenic food.
Perkin MR. et al, (2019), J Allergy Clin Immunol, 144, 1595 - 1605
Dog ownership at three months of age is associated with protection against food allergy
Marrs T. et al, (2019), Allergy: European Journal of Allergy and Clinical Immunology, 74, 2212 - 2219